Cristina Legido-Quigley appointed new Principal Investigator at Steno Diabetes Center Copenhagen

Associate Professor Cristina Legido-Quigley from King’s College London is set to join Steno Diabetes Center Copenhagen (SDCC) as its new Principal Investigator of the System Medicine research group.

Birgitte Brock, Head of Research at SDCC, has appointed Cristina Legido-Quigley as the new Principal Investigator of the Systems Medicine research group.

"Cristina Legido-Quigley is an international figure with solid technical knowledge and a background in the relevant research fields falling within the scope of the SDCC research strategy. In addition, she has leadership experience from her current employment at King's College London. This unique combination represents the profile we have sought in a Principal Investigator for Metabolomics and Systems Medicine, which will ensure continued development of world-class research. The appointment of Cristina reinforces SDCC's focus on developing patient related analyses in this area, which is in line with the overall plan for SDCC", said Birgitte Brock, Head of Research at SDCC.

Cristina Legido-Quigley comes from a positon as Associate Professor at the Institute of Pharmaceutical Science, King’s College London. Her research interest is in the field of finding clinical biomarkers of brain diseases related to aging and studying the body’s metabolism with a clinical translational focus.

“What motivates me is working so closely with the clinic at SDCC. That gives me and my team an opportunity to take research into the clinic and make a difference to patients,” Cristina Legido-Quigley says. She looks forward to concentrating on research projects and collaborating with the research groups at SDCC and the University of Copenhagen.

Her ambition is to find out how the body as a whole maintains a healthy brain, taking into account that our genetic make-up, chronic metabolic disease, and life-style will be interconnected.

“Metabolomics, which is my expertise, is basically a very powerful discovery tool - one can use it to do research into finding small molecules present in the blood and use it in diagnostics, ideally to identify if a patient is at risk. Another application is to have an approach where you get clues into what molecules could help with a particular condition, such as memory problems. It is a very versatile technique,” Cristina Legido-Quigley explains.

Cristina Legido-Quigley will start as Principal Investigator of Systems Medicine at SDCC on 1 January 2018.

Responsible editor